United Services Automobile Association Clovis Oncology, Inc. Transaction History

United Services Automobile Association

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 16, 2019	SELL	$12.81 - $25.67 $111,203 - $222,841	-8,681 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$17.66 - $30.28 $153,306 - $262,860	8,681 New	8,681 $215,000
Q4 2018 Feb 13, 2019	SELL	$11.63 - $32.67 $100,960 - $283,608	-8,681 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$42.06 - $62.4 $39,115 - $58,032	930 Added 12.0%	8,681 $395,000
Q1 2018 May 14, 2018	BUY	$50.12 - $67.72 $388,480 - $524,897	7,751 New	7,751 $409,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.